Skip to main content
OpenTrials
Completed

NCT Number: NCT07510243

Effects of Mulligan Mobilization With Movement Versus Kinesiotaping and Placebo on Knee Function and Injury -Related Outcomes in Basketball Players

This is a randomized RTC study where the KOS-ADLS score of athletes' functionality and the OSTRC score of sports overuse injuries were used as outcomes, which were measured before the start of treatment, 1 hour and 2 weeks after treatment. In this study, 3 forms of intervention were used: Mulligan, Kinesiotaping and placebo in young basketball players with knee injuries.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–22 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sports Club Training facilities

Tirana, 1001, Albania

About this study

Study type: Randomized Clinical Trial RTC ,with three intervention groups. Population: young basketball players. The intervention will last 2 weeks. Outcomes: KOS-ADLS; OSTRC. Statistical analysis: Mixed ANOVA

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male and female basketball players Minimum of 2 years of sports experience Presence of knee injury Active participation in organized sports

Exclusion criteria

Previous knee surgery Knee instability Neurological disorders Refusal or contraindication to Mulligan mobilization

Treatment and study plan

Mulligan Mobilization with movement MWM

Other

Participants received the MWM technique in a squat position with a tibial glide by a physiotherapist certified in the mulligan concept twice a week for 2 weeks, the treatment lasted 5 minutes.

Kinesiotaping

Other

Participants received the same kinesiotaping pattern regardless of injury type twice a week for 2 weeks for 5 minutes.

Placebo

Other

Participants received a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks, lasting 5 minutes.

Primary outcomes

  1. KOS-SAS (ADLS)

    Time frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention

    The Activities of Daily Living Scale (ADLS) subscale of the Knee Outcome Survey evaluates symptoms and functional limitations during daily activities. Scores range from 0 to 100, with higher scores indicating better function.

Secondary outcomes

  1. Overuse Injury Questionnaire - Oslo Sports Trauma Research Center (OSTRC)

    Time frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention

    The Oslo Sports Trauma Research Center (OSTRC) Overuse Injury Questionnaire is a validated self-report instrument used to monitor the severity and impact of overuse-related musculoskeletal problems. It evaluates the consequences of knee-related problems on sports participation, training volume, sports performance, and symptom severity. Responses to the four key questions are converted into a severity score ranging from 0 to 100, where higher scores indicate greater symptom severity and functional impairment.

Other outcomes

  1. Sports Activity Scale (SAS) - Knee Outcome Survey.

    Time frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention

    The Sports Activity Scale (SAS) of the Knee Outcome Survey assesses knee symptoms and functional limitations during sports and higher-level activities. The scale ranges from 0 to 100, with higher scores indicating better sports-related knee function.

Sponsors and collaborators

Lead sponsor

University Aleksander Moisiu Durres

Other

Registry information

Official study title

Effects of Mulligan Mobilization With Movement Versus Kinesiotaping and Placebo on Knee Function and Injury -Related Outcomes in Basketball Players: A Parallel -Group Randomized Controlled Trial

Acronym: Sport _MWM_RTC

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Apr 3, 2026
Registry last updated
Apr 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.